Outrunning Cancer-Related Fatigue
When Honora Miller, 53, wondered how to explain her cancer-related fatigue to her son, a friend recommended using an analogy involving spoons. The spoon theory held that Miller would start each day with a certain number of the utensils, each one representing energy. Each daily activity cost a spoon.
MDS Treatment, Inqovi: Dr. Amer Zeidan Explains the Use of this Treament
The recently-approved hypomethylating treatment, Inoqvi, is a daily oral version of two IV or subcutaneous medications. Listen to Dr. Amer Zeidan of Yale Cancer Center explain which MDS patients could qualify, and what it means for their treatment at the link.
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults
Oral Hypomethylating Agent Regimen Approved for MDS Improves Outpatient Treatment Options
FDA Grants Aspacytarabine Fast Track Status for Older Patients With AML
Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes
Dealing with Stress and Anxiety as a Cancer Survivor
Disease recurrence is a common cause for the stress and anxiety typically experienced by cancer survivors even long after treatment ends. Several mental health experts provide some tips for easing these fears.
June 2020 Vol 6 No 3
Adam Buffery
Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes
Abstract
Background